These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients. Zirk-Sadowski J; Masoli JA; Strain WD; Delgado J; Henley W; Hamilton W; Melzer D; Ble A Am J Gastroenterol; 2017 Mar; 112(3):520-523. PubMed ID: 28270664 [No Abstract] [Full Text] [Related]
23. The dangers of proton pump inhibitor therapy. Owen C; Marks DJ; Banks M Br J Hosp Med (Lond); 2014 Jul; 75(7):C108-12. PubMed ID: 25152941 [No Abstract] [Full Text] [Related]
24. [Adverse effects of long-term proton-pump inhibitor therapy on adults]. Igaz I; Simonyi G; Balogh S; Szathmári M Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946 [TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers. de Vries F; van Staa TP; Leufkens HG Osteoporos Int; 2011 May; 22(5):1641-2. PubMed ID: 20563562 [No Abstract] [Full Text] [Related]
26. Long-term therapy with proton pump inhibitors is associated with decreased bone density. Bratanic A; Kokic S; Hozo I; Barisic I; Kokic V Med Hypotheses; 2009 May; 72(5):608-9. PubMed ID: 19217215 [No Abstract] [Full Text] [Related]
27. Acid suppressants and hip fracture: duplicate publication bias? Bazelier M; de Boer A; de Vries F Bone; 2011 Oct; 49(4):920; author reply 921. PubMed ID: 21820528 [No Abstract] [Full Text] [Related]
28. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor. Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607 [No Abstract] [Full Text] [Related]
29. Opportunities to decrease inappropriate uses of proton pump inhibitors: Comment on "Proton pump inhibitor use and the antifracture efficacy of alendronate". Katz MH Arch Intern Med; 2011 Jun; 171(11):1004-5. PubMed ID: 21321289 [No Abstract] [Full Text] [Related]
30. The effect of proton pump-inhibiting drugs on mineral metabolism. Insogna KL Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542 [TBL] [Abstract][Full Text] [Related]
31. Fracture risk with PPIs and allergy to IV contrast. Dedea L JAAPA; 2010 Aug; 23(8):13. PubMed ID: 20821906 [No Abstract] [Full Text] [Related]
32. Acid suppressants, fracture, and statistical adjustments for body mass index, smoking status, and calcium/vitamin D intake. de Vries F Am J Gastroenterol; 2011 Nov; 106(11):2051. PubMed ID: 22056590 [No Abstract] [Full Text] [Related]
33. Proton Pump Inhibitors and Fractures During Growth. Sugiyama T JAMA Pediatr; 2021 Feb; 175(2):208-209. PubMed ID: 32986077 [No Abstract] [Full Text] [Related]
34. Proton Pump Inhibitors and Fractures During Growth-Reply. Wang YH; Pasternak B JAMA Pediatr; 2021 Feb; 175(2):209-210. PubMed ID: 32986123 [No Abstract] [Full Text] [Related]
35. Will heartburn break your leg? Stevenson JC Maturitas; 2012 Jun; 72(2):97-8. PubMed ID: 22516279 [No Abstract] [Full Text] [Related]
39. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia]. Doornebal J; Bijlsma R; Brouwer RM Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736 [TBL] [Abstract][Full Text] [Related]
40. Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis. Lai SW; Kuo YH; Liao KF Ann Rheum Dis; 2020 Dec; 79(12):e156. PubMed ID: 31300456 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]